Published on
March 24, 2026
- 16:37 GMT
Madorra Enrolls First Patient in Pivotal Trial for Treatment of Moderate to Severe Vulvovaginal Atrophy: The WAVES Study
Breakthrough Device-Designated Therapy System Takes Important Step Toward Market Authorization PORTLAND, OR, UNITED STATES, March 24, 2026 /EINPresswire.com/ -- Madorra Inc., a medical device company developing innovative solutions for menopause-related …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
